Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.98 CNY | +0.74% |
|
+0.37% | +7.72% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 14.45x | 2.71x | 0.7x | 0.6x | 4.77x | 7.87x | 4.78% | 3.17B | |
| 17.84x | 1.57x | 2.22x | 0.75x | 11.77x | 12.64x | -.--% | 15.44B | |
| 23.37x | 2.59x | 3.9x | 0.93x | 16.39x | 16.65x | 0.97% | 7.07B | |
| 16.95x | 1.78x | 1.85x | 0.76x | 7.92x | 10.01x | 2.21% | 6.22B | |
| 14.21x | 2.13x | 0.87x | 0.91x | 6.6x | 8.64x | 3.02% | 4.02B | |
| 14.4x | 4.41x | 6.69x | 1.23x | 7.5x | 14.1x | 5.32% | 3.26B | |
| 14.92x | 6.75x | 2.28x | 0.91x | 6.73x | 9.35x | 4.3% | 3.04B | |
| 40.84x | - | 1.3x | - | - | - | - | 2.65B | |
| -94.33x | 2.97x | 1.53x | 0.47x | 17.41x | 105.75x | 0.01% | 1.55B | |
| 21.5x | 3.76x | 0.93x | 0.62x | 7.97x | 13.05x | 1.91% | 1.55B | |
| 12.16x | 0.87x | 0.12x | 0.29x | 2.8x | 5.77x | 4.17% | 964M | |
| 14.44x | 2.39x | -0.55x | 0.85x | 6.9x | 14.84x | 5.78% | 915M | |
| 40.97x | 3.91x | -6.3x | 0.95x | 11.93x | 22.58x | - | 881M | |
| 26.4x | 7.2x | 0.98x | 0.96x | 13.03x | 20.2x | 1.36% | 792M | |
| 15.4x | 2.08x | 1.27x | 0.73x | 8.88x | 14.34x | 0.34% | 748M | |
| Average | 12.90x | 3.22x | 1.19x | 0.78x | 9.33x | 19.70x | 2.63% | 3.48B | |
| Weighted average by Cap. | 15.87x | 2.62x | 2.12x | 0.81x | 10.26x | 15.31x | 1.88% |
Select your edition
All financial news and data tailored to specific country editions
